Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
Hardoy Maria Carolina*, Carta Mauro Giovanni
Identifiers and Pagination:Year: 2010
First Page: 1
Last Page: 3
Publisher ID: CPEMH-6-1
Article History:Received Date: 7/9/2009
Revision Received Date: 1/11/2009
Acceptance Date: 1/11/2009
Electronic publication date: 27/1/2010
Collection year: 2010
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
The topic of early response to antidepressant treatment has been extensively studied in major depressive disorder (MDD). We serendipitous observed an increase tolerability, a rapid response to therapy and an early onset of antidepressant fluvoxamine activity when associated with amisulpride in patients with major depressive disorder. The purpose of this study was to investigate our preliminary observations.